Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A genome DNA sequence (disease-specific) refers to the complete or partial nucleotide sequence of an organism’s genome, with a focus on regions or variants associated with a particular disease. This target is not a single molecule but rather specific stretches of DNA—often genes, regulatory elements, or mutation sites—that are implicated in the onset, progression, or risk of diseases such as cancer, inherited disorders, and complex conditions like diabetes. Identifying pathogenic variants in these sequences can provide definitive diagnoses for genetic diseases and inform treatment decisions. Analysis of individual genomes allows clinicians to assess disease risk more accurately than family history alone and tailor prevention strategies accordingly. In oncology and rare diseases, sequencing tumor genomes can reveal actionable mutations that guide targeted therapy selection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Genome DNA sequence (disease-specific).